LOCKHEED MARTIN INVESTMENT MANAGEMENT CO

Position in NVO — Novo Nordisk A S

CIK 897599 BETHESDA, MD

Position in NVO

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,481,346

+$345,771 QoQ

Shares Held

30,900

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#433

of 1,348 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

LOCKHEED MARTIN INVESTMENT MANAGEMENT CO holds $85,820,334 across 7 Drug Manufacturers - General names. NVO ranks #7 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	171,210	$43,482,203
2	LLY	ELI LILLY & Co	13,090	$15,700,540
3	ABBV	AbbVie Inc.	41,130	$10,349,953
4	NVS	Novartis AG	48,400	$7,585,248
5	MRK	Merck & Co., Inc.	32,500	$4,176,250
6	GILD	Gilead Sciences, Inc.	24,100	$3,044,794
7	NVO	Novo Nordisk A S This page	30,900	$1,481,346

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,481,346	30,900	0.0%	Shares	Sole	2026-08-12
2026-03-31	$1,135,575	30,900	+10.6%	Shares	Sole	2026-05-07
2025-12-31	$1,422,096	27,950	0.0%	Shares	Sole	2026-02-05
2025-09-30	$1,550,945	27,950	-35.7%	Shares	Sole	2025-10-30
2025-06-30	$2,998,919	43,450	+179.4%	Shares	Sole	2025-08-04
2025-03-31	$1,079,792	15,550	-78.6%	Shares	Sole	2025-05-12
2024-12-31	$6,240,751	72,550	+286.9%	Shares	Sole	2025-01-27
2024-09-30	$2,232,562	18,750	-38.3%	Shares	Sole	2024-11-14
2024-06-30	$4,339,296	30,400	-6.3%	Shares	Sole	2024-08-07
2024-03-31	$4,167,864	32,460	-11.5%	Shares	Sole	2024-05-13
2023-12-31	$3,792,477	36,660	—	Shares	Sole	2024-02-12
No filing history on record for this holder in this stock.